The primary method for breast cancer detection today are mammograms, however mammograms can only show abnormalities. It is difficult for a doctor to tell if a growth is malignant or benign.
Now a new technology is starting to be used to compliment mammograms in cases where they are inconclusive. Nuclear Functional Imaging uses a radiopharmaceutical to tag cells in the body. The drug contains a component designed to latch on to cells of interest to doctors and a radioactive agent that releases gamma rays as it decays over time. For example, Technetium-99m-Sestamibi has been found to accumulate in breast tumors. Over time, the Technetium-99m (Tc99m) decays, giving off gamma rays. A medical gamma-ray imager, can spot these gamma rays and reveal the hidden cancer.